Silverback Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-788,011
Closed -$442K – 56
2019
Q3
$442K Hold
788,011
– – 0.07% 48
2019
Q2
$410K Hold
788,011
– – 0.06% 49
2019
Q1
$355K Hold
788,011
– – 0.06% 42
2018
Q4
$378K Hold
788,011
– – 0.07% 52
2018
Q3
$418K Hold
788,011
– – 0.07% 49
2018
Q2
$394K Buy
788,011
+338,011
+75% +$157K 0.05% 47
2018
Q1
$190K Hold
450,000
– – 0.04% 47
2017
Q4
$171K Hold
450,000
– – 0.03% 49
2017
Q3
$162K Hold
450,000
– – 0.03% 50
2017
Q2
$171K Buy
+450,000
New +$184K 0.06% 27
2016
Q1
– Sell
-861,200
Closed -$97K – 78
2015
Q4
$97K Sell
861,200
-63,100
-7% -$8.91K 0.02% 41
2015
Q3
$176K Sell
924,300
-102,100
-10% -$34.7K 0.02% 40
2015
Q2
$718K Hold
1,026,400
– – 0.1% 40
2015
Q1
$696K Hold
1,026,400
– – 0.14% 40
2014
Q4
$811K Buy
1,026,400
+101,800
+11% +$69.5K 0.1% 45
2014
Q3
$430K Hold
924,600
– – 0.05% 45
2014
Q2
$462K Sell
924,600
-657,810
-42% -$318K 0.05% 55
2014
Q1
$491K Sell
1,582,410
-581,099
-27% -$216K 0.03% 58
2013
Q4
$736K Buy
2,163,509
+655,271
+43% +$792K 0.06% 56
2013
Q3
$3.05M Buy
1,508,238
+508,238
+51% +$968K 0.26% 52
2013
Q2
$1.9M Buy
+1,000,000
New +$1.76M 0.17% 51

Other funds holding GCVRZ

Silverback Asset Management's GCVRZ Position: Q4 2019 in Review

Silverback Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2019, closing a stake of 788,011 shares — an estimated $442K sold.

Silverback Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 21 quarters. The position peaked at $3.05M in Q3 2013. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • Silverback Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Silverback Asset Management sold 788,011 Sanofi Contingent Value Rights shares in Q4 2019, an estimated $442K.
  • Silverback Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 21 quarters.
  • Silverback Asset Management's Sanofi Contingent Value Rights position peaked at $3.05M in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on Silverback Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.